Silver Book Fact

Blood Pressure Control in Patients with Diabetes

Fact image

Tight blood pressure control in type 2 diabetes patients reduced progression of DR by 34% and risk of deterioration by 47% after 9 years.

UK Prospective Diabetes Study Group. Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38. BMJ. 1998; 317: 703. http://www.bmj.com/content/317/7160/703

Reference

Title
Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38
Publication
BMJ
Publication Date
1998
Authors
UK Prospective Diabetes Study Group
Pages
703
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • The Diabetes Prevention Program showed that exercise and dietary changes targeting a 7 percent weight loss in participants with prediabetes reduced type 2 development by 58 percent over three years.  
  • Every additional dollar spent on the overall treatment of type 2 diabetes has produced health gains valued at $1.49.  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.  
  • The cost effectiveness ratio for pump therapy compared with daily insulin injections is about $18,000 per life year saved.